Tami Mark

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter

Filter by Type

Filter by Focus Area

Filter by Solution

Search Results

New research finds racial disparity in use and access to medications for opioid use disorder

Buprenorphine prescribing for Medicaid beneficiaries down in 2020

Expert available to comment on DOJ guidance on ADA protections for people with opioid use disorders

Pandemic stress and loneliness are making addiction more common: When to get help

First-of-its-kind research article details substance use disorder prevalence among Medicare beneficiaries and the treatment barriers they face

New implementation toolkit released to help states improve opioid use disorder treatment

RTI announces new Fellow Program appointments and promotions

Study: Costs to add substance abuse coverage to Medicare to only increase spending by nominal amount

Changes in Buprenorphine prescribing to Medicaid beneficiaries during the first year of the COVID-19 pandemic

Substance use disorders among Medicare beneficiaries: Prevalence, mental and physical comorbidities, and treatment barriers

Medicare needs to cover the full spectrum of care for substance use disorders

Addiction treatment and telehealth: Review of efficacy and provider insights during the COVID-19 pandemic

New study shows nominal cost of adding substance use disorder services to Medicare

Assessing assessments: Substance use disorder treatment providers' perceptions of intake assessments

What's in an "ASAM-based Assessment?" Variations in assessment and level of care determination in systems required to use ASAM patient placement criteria

Growth in use of medications to treat opioid use disorders stalled during pandemic, study finds

AcademyHealth 2022 Annual Research Meeting

Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder

Development, testing, and dissemination of a public-facing tool to help consumers find higher-quality addiction treatment